Title
Trial Comparing hCG Triggering Versus hCG Associated With GnRH Agonist
Randomised Controlled Trial Comparing hCG Triggering Versus hCG Associated With GnRH Agonist
Phase
Phase 4Lead Sponsor
AZ Jan Palfijn GentStudy Type
InterventionalStatus
Completed Results PostedIndication/Condition
InfertilityIntervention/Treatment
triptorelin human choriogonadotropin alfa ...Study Participants
120The purpose of this study is to see whether patients triggered with only human Chorion Gonadotropin (hCG) have higher number of Metaphase II oocytes (MII) and implantation rate than patients triggered with hCG combined with Gonadotropin Releasing Hormone (GnRH) agonist.
Decapeptyl 0.2 mg SC once 1day
5000 IU SC
5000 IU Pregnyl SC + 0.2 mg Decapeptyl daily SC
Inclusion Criteria: Intra-cytoplasmic sperm injection (ICSI) patients below 38 years 1,2 or 3 rd IVF-cycle Exclusion Criteria: polycystic ovary syndrome (PCOS) patients patients with endocrinological diseases or problems
Event Type | Organ System | Event Term | hCG TRIGGERING | hCG and GnRH Agonist Triggering |
---|
the number of mature oocytes retrieved
the number of pregnancies obtained, wich still is the most important issue for the patients